Pharmaceutical Biotechnology & Clinical Research Jobs $ImmunityBio, Inc.(IBRX)$$Spdr S&P Biotech Etf(XBI)$ $S&P Biotech Bull 3X Shares(LABU)$ So a company thats got PDUFA on or before May 23 Is hiring but shorts keep pounding the SP two months out. The price was 6.80 in Dec and now 1.50 and little has changed except a 14 mil share direct offering at 3.50 to several institutions. đ¤ˇđźââď¸. This is going to run so hard soon!!! Billionaire owner Patrick Soon Shiong already got abraxane approved and sold the company to Celgene. Approval almost certain for the Bladder cancer drug Anktiva. Do your DD. Never invest more than you can afford to lose!So short term charts are screaming a bounce coming next. 1H, 2H, 4H are all in solid oversold territory. Daily has some room to go. Weekly is a very different story. Take a look below and judge for yourself what comes next:
Comments